Search research articles
Contact Us
Filters
Showing results (61-70 of 116) with videos related to
Page
of 12
Sort By:
Oncotarget
|
November 8, 2017
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy
May Cho, Jun Gong, Paul Frankel, et al.
Journal of Gastrointestinal Oncology
|
January 5, 2018
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer
Joseph Chao, James Lin, Paul Frankel, et al.
Frontiers in Oncology
|
December 19, 2019
Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis
Yunhe Gao, Hongqing Xi, Bo Wei, et al.
Annals of Translational Medicine
|
August 25, 2021
Narrative review of pembrolizumab for the treatment of esophageal cancer: evidence and outlook
Zixian Jin, Jianfei Shen, Chunguo Wang, et al.
The Oncologist
|
August 6, 2021
Recall of Genomic Testing Results Among Patients with Cancer
Sam E Wing, Hengrui Hu, Lisa Lopez, et al.
Blood
|
October 9, 2004
The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis
Mingjiang Xu, Edward Bruno, Joseph Chao, et al.
Journal of Gastric Cancer
|
July 3, 2024
Diffuse-Type Histology Is Prognostic for All Siewert Types of Gastroesophageal Adenocarcinoma
Kelly M Mahuron, Kevin M Sullivan, Matthew C Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses
Nicola R Hardwick, Mary Carroll, Teodora Kaltcheva, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 28, 2013
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
Scott Eliasof, Douglas Lazarus, Christian G Peters, et al.
The Oncologist
|
June 29, 2019
<i>FGFR2</i>-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape
Samuel J Klempner, Russell Madison, Vivek Pujara, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 116) with videos related to
Sort By:
Page
of 12
Oncotarget
|
November 8, 2017
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy
May Cho, Jun Gong, Paul Frankel, et al.
Journal of Gastrointestinal Oncology
|
January 5, 2018
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer
Joseph Chao, James Lin, Paul Frankel, et al.
Frontiers in Oncology
|
December 19, 2019
Association Between Liquid Biopsy and Prognosis of Gastric Cancer Patients: A Systematic Review and Meta-Analysis
Yunhe Gao, Hongqing Xi, Bo Wei, et al.
Annals of Translational Medicine
|
August 25, 2021
Narrative review of pembrolizumab for the treatment of esophageal cancer: evidence and outlook
Zixian Jin, Jianfei Shen, Chunguo Wang, et al.
The Oncologist
|
August 6, 2021
Recall of Genomic Testing Results Among Patients with Cancer
Sam E Wing, Hengrui Hu, Lisa Lopez, et al.
Blood
|
October 9, 2004
The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis
Mingjiang Xu, Edward Bruno, Joseph Chao, et al.
Journal of Gastric Cancer
|
July 3, 2024
Diffuse-Type Histology Is Prognostic for All Siewert Types of Gastroesophageal Adenocarcinoma
Kelly M Mahuron, Kevin M Sullivan, Matthew C Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 3, 2014
p53MVA therapy in patients with refractory gastrointestinal malignancies elevates p53-specific CD8+ T-cell responses
Nicola R Hardwick, Mary Carroll, Teodora Kaltcheva, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 28, 2013
Correlating preclinical animal studies and human clinical trials of a multifunctional, polymeric nanoparticle
Scott Eliasof, Douglas Lazarus, Christian G Peters, et al.
The Oncologist
|
June 29, 2019
<i>FGFR2</i>-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic Landscape
Samuel J Klempner, Russell Madison, Vivek Pujara, et al.
Page
of 12